MIM
ADNT icon

MetLife Investment Management’s Adient ADNT Stock Holding History

MetLife Investment Management’s Portfolio ADNT Stock Details ADNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$923K Sell
45,654
-433
-0.9% -$9.63K ﹤0.01% 1441
2025
Q4 		$883K Sell
46,087
-3,707
-7% -$78K ﹤0.01% 1499
2025
Q3 		$1.2M Sell
49,794
-258
-0.5% -$6.03K 0.01% 1339
2025
Q2 		$974K Buy
50,052
+1,307
+3% +$19.3K 0.01% 1331
2025
Q1 		$627K Sell
48,745
-6,093
-11% -$98K ﹤0.01% 1603
2024
Q4 		$945K Buy
54,838
+2,937
+6% +$58.7K 0.01% 1448
2024
Q3 		$1.17M Sell
51,901
-45,690
-47% -$1.05M 0.01% 1309
2024
Q2 		$2.41M Buy
97,591
+2,331
+2% +$66.2K 0.01% 884
2024
Q1 		$3.14M Sell
95,260
-5,084
-5% -$173K 0.02% 752
2023
Q4 		$3.65M Buy
+100,344
New +$3.44M 0.03% 662
2023
Q3 		– Sell
-104,897
Closed -$4.02M – 2891
2023
Q2 		$4.02M Sell
104,897
-946
-0.9% -$35K 0.03% 580
2023
Q1 		$4.34M Sell
105,843
-2,187
-2% -$91.3K 0.03% 533
2022
Q4 		$3.75M Sell
108,030
-1,203
-1% -$42.1K 0.03% 604
2022
Q3 		$3.03M Sell
109,233
-720
-0.7% -$23.4K 0.03% 688
2022
Q2 		$3.26M Buy
109,953
+266
+0.2% +$8.94K 0.03% 676
2022
Q1 		$4.47M Buy
109,687
+31,387
+40% +$1.35M 0.03% 605
2021
Q4 		$3.75M Buy
78,300
+396
+0.5% +$17.8K 0.03% 550
2021
Q3 		$3.23M Sell
77,904
-1,810
-2% -$72.1K 0.03% 601
2021
Q2 		$3.6M Sell
79,714
-4,127
-5% -$193K 0.03% 562
2021
Q1 		$3.71M Sell
83,841
-2,804
-3% -$106K 0.03% 552
2020
Q4 		$3.01M Sell
86,645
-6,405
-7% -$181K 0.03% 619
2020
Q3 		$1.61M Buy
93,050
+1,905
+2% +$33.2K 0.02% 813
2020
Q2 		$1.5M Buy
91,145
+1,881
+2% +$28.6K 0.02% 848
2020
Q1 		$810K Hold
89,264
– – 0.01% 994
2019
Q4 		$1.9M Sell
89,264
-674
-0.7% -$14.9K 0.02% 834
2019
Q3 		$2.06M Buy
89,938
+38,403
+75% +$876K 0.02% 777
2019
Q2 		$1.25M Sell
51,535
-1,498
-3% -$30.8K 0.01% 1010
2019
Q1 		$687K Buy
+53,033
New +$928K 0.01% 1265

Other funds holding ADNT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

MetLife Investment Management's ADNT Position: Q1 2026 in Review

MetLife Investment Management reduced its Adient (ADNT) stake by 0.94% in Q1 2026, selling an estimated $9.63K and leaving 45,654 shares worth $923K. The position accounts for ﹤0.01% of the portfolio, ranked #1441.

MetLife Investment Management first reported a position in ADNT in Q1 2019 and has held it in 28 quarters since. The position peaked at $4.47M in Q1 2022. 287 funds tracked by Wall St. Rank hold ADNT as of Q1 2026.

  • MetLife Investment Management held 45,654 shares of Adient worth $923K as of Q1 2026.
  • MetLife Investment Management sold 433 Adient shares in Q1 2026, an estimated $9.63K.
  • Adient made up ﹤0.01% of MetLife Investment Management's portfolio in Q1 2026, its #1441 holding.
  • MetLife Investment Management first reported a position in Adient in Q1 2019 and has held it in 28 quarters since.
  • MetLife Investment Management's Adient position peaked at $4.47M in Q1 2022.
  • 287 funds tracked by Wall St. Rank held Adient as of Q1 2026.

Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.